Doris A. Taylor, PhD


Dr. Taylor is a dynamic innovator, scientist and entrepreneur and a global thought leader in regenerative medicine. She has published close to 200 papers, holds over 30 patents, and is the founder of multiple companies. She has trained hundreds of undergraduate, graduate, and post-graduate fellows worldwide in her laboratories in the U.S. and Europe. Although she has held academic positions for over 20 years, she recently founded RegenMedix Consulting LLC to enable academic and commercial enterprises in the regenerative medicine space.

Dr. Taylor is credited with the first functional scientific repair of injured heart with stem cells in 1998. Her group further transformed the field of organ transplantation science in 2008 by developing a unique cell removal (decellularization) method that makes un-transplantable organs into usable scaffold frameworks for building new organs with stem cells. This was so revolutionary it was recognized as one of the “Top 10 Research Advances” by the American Heart Association and Taylor was nominated as one of “100 most influential people in the world” by Time magazine. Next, she turned to disease prevention and has begun to develop “cellular signatures” of heart disease and aging that appear to differ by age sex race and ethnicity.

Dr. Taylor frequently appears as an expert on cell therapy, women’s health, cardiac repair and organ transplantation in the public media. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Forbes, National Geographic, BBC Horizon, BBC News Health, ABC, NBC and CBS News, Associated Press, Good Morning America, , the Oprah Winfrey Show, NOVA  Science Now, PBS NOVA, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, NPR’s On Being with Krista Tippet and most other worldwide media outlets.

Dr. Taylor sits on numerous think tanks and international scientific committees including for the NIH, the FDA, the American Association of Blood Banks, and the Alliance for Regenerative Medicine. She is a member of the Leadership Advisory Committee for the Advanced Regenerative Manufacturing Institute (ARMI) and sits on the international jury for the Institut de France LeFoulon-Delalande Foundation Grand Prix which is awarded annually to individuals making worldwide contributions to cardiovascular medicine.

Dr. Taylor earned a bachelor’s degree from Mississippi University for Women (MUW) and a Ph.D. from UT Southwestern Medical Center.